[1] |
BAI Xin, WANG Min, WANG Yuan, BAI Jianqi, SU Shuang, LIU Guanghui, GUO Xiaofei, KANG Jiaqi, GUO Dongqi, ZHANG Yimeng, WANG Hao, ZHAO Xiaoqi, ZHANG Ping.
Traditional Chinese Medicine Used in the Treatment of Gout Complicated with Osteoarthritis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 258-262.
|
[2] |
LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun.
Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654.
|
[3] |
XIE Zhiqiang, YUAN Jiqiao, LI Jialin, LIU Zhengyue, WANG Manyuan.
Therapeutic effect and immune mechanism of artemisia annua L. ointment on mouse eczema models
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 617-624.
|
[4] |
HUANG Wei, LUO Yaqin, YU Xinyang, DONG Hongjing, WANG Xiao.
Mechanisms of extracts of Pith-nodecayed and Pith-decayed of Scutellariae Radix against Th17/Treg immune imbalance in damp-heat ulcerative colitis rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 535-539.
|
[5] |
YAO Rongmei, MAO Xin, XU Yingli, ZHANG Zhibin, GAO Yingjie, BAO Lei, BAO Yanyan, MENG Fengxian, CUI Xiaolan.
Effect of Tutengcao granules on MSU-induced acute gouty arthritis in rabbits
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 263-268.
|
[6] |
LI Yamei, SHUI Rong.
Research progress in tofacitinib for juvenile idiopathic arthritis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 956-960.
|
[7] |
LUO Qiong, LI Meng, LI Guangyao, HE Yanchun, ZHOU Zushan, SUN Xin, LIU Chenghai.
Chinese medical evidence and characteristics of combined medication in 635 cases of rheumatoid arthritis patients with liver injury caused by the application of Tripterygium wilfordii preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 500-504.
|
[8] |
FU Changli, LU Yuan, CHEN Siying, WANG Yonglin, LI Yongjun, WANG Aimin, LIU Chunhua.
Mechanisms of Laportea bulbifera against rheumatoid arthritis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 171-176.
|
[9] |
LI Yuan, BAI Zhiyi, WANG Haiyu, QIAN Tangliang, WANG Ruoyi, KANG Tianlun, DU Mengmeng, BAI Xuejiao, LIU Xiaoping, HOU Xiujuan.
Interventional effect and safety of modified Shaoganfuzi decoction with different doses in CIA rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 962-966.
|
[10] |
CUI Xiangli, ZHANG Zhiqi, SUN Liying, GUO Mingxing, ZENG Zhigui, XU Wanyi.
Leflunomide-induced hepatotoxicity: data analysis based on the FDA adverse event reporting system
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 426-431.
|
[11] |
ZHANG Yuting, ZHU Yuelan, HOU Xiujuan.
Difference between CIA Rat Models of Different Ages and Intervention Effect and Safety of Modified Shaoganfuzi Decoction
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1129-1133.
|
[12] |
XING Yuqi, ZHANG Yuqiu, ZHANG Guobin.
Anti-rejection Effect of Triptolide on Experimental Skin Transplantation in Mice
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 523-527.
|
[13] |
ZHANG Xiao-meng, LIN Zhi-jian, ZHANG Bing, LI Min.
Comparison of Aconitum with Tripterygium in Treatment of Axial Spondyloarthritis: A Benefit-risk Assessment
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(2): 103-109.
|
[14] |
ZHU Shuai, HUANG Yu-peng, HE Yong, NIE Xin, WANG Wei-qing, DU Xiang-yang, GUO Ying, LI Gui-xing.
Clinical Observation of Etanercept Combined with Methotrexate in Treatment of Patients with Rheumatoid Arthritis
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(5): 266-268.
|
[15] |
LUAN Yong-fu, SUN Rong.
Advances in Establishments of Animal Models with Rheumatoid Arthritis and Thinking about Efficacy Evaluation of TCM
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(4): 219-221.
|